Welcome to the MarketReader Minute.

Below are AI-generated insights on today’s premarket moves, powered by MarketReader technology.

If you find the insights useful, you may subscribe to our new sector-specific newsletters or share this on Twitter.

Friday, September 5

Noteworthy macro moves today: US 2Y Treasury Bond +0.2%. US 10Y Treasury Bond +0.5%. US Dollar Index -0.6%. Noteworthy US mega-cap moves today: Broadcom Inc (AVGO) +14.1%. 

The U.S. labor market data released today indicates a significant slowdown, with nonfarm payrolls increasing by only 22,000 jobs in August—well below the expected gain of 75,000 and down from an upwardly revised figure of 79,000 for July. The unemployment rate also rose to 4.3%, matching forecasts and marking its highest level since October 2021.

In Europe, Germany's factory orders fell sharply by 2.9% month-on-month in July against expectations for growth of just 0.5%. This marks the third consecutive monthly decline and highlights ongoing challenges within Europe's manufacturing sector amid broader economic uncertainties.

Ethereum (ETH/USD) [+3.3%]
Ethereum (ETH/USD) has seen a notable increase of over 3% today. This rise coincides with significant outflows from global cryptocurrency markets, where Ethereum and Bitcoin exchange-traded funds recorded withdrawals exceeding $678 million in a single day. Concurrently, the U.S. employment report for August revealed a slowdown in job growth, with only 22,000 jobs added, falling short of expectations. Social media activity highlights that BITMINE IMMERSION has augmented its Ethereum holdings, while an Ethereum whale staked 150,000 ETH valued at approximately $661 million. Additionally, SharpLink Gaming has increased its reserves to 837,230 ETH, nearly 0.7% of the total supply. BlackRock's recent purchase of $148.8 million worth of ETH further reflects ongoing accumulation in the market. Meanwhile, Bitcoin (BTC/USD) has increased by 1.7%, reflecting broader market sentiment that often influences Ethereum's performance.

EUR/USD (EUR/USD) [+0.7%]
The EUR/USD has increased, reflecting a daily return influenced by the release of U.S. employment data, which showed only 22,000 jobs added in August, well below expectations and suggesting a cooling labor market. This has fueled speculation regarding potential aggressive interest rate cuts by the Federal Reserve. Concurrently, gold prices have surged above 3,500 an ounce amid concerns over economic stability and a weakening dollar. Social media discussions highlight the recent pullback of the U.S. dollar ahead of the jobs report, overshadowing disappointing German factory orders that fell by 2.9%. The unemployment rate in the U.S. rose to 4.3%, its highest since 2021, while average hourly earnings remained steady. In related movements, GBP/USD has risen, reflecting broader market sentiment that may also influence EUR/USD.

GWRE | +14.5% | +3.0B
Guidewire Software Inc | Application Software
Guidewire Software Inc (GWRE) saw a significant stock price increase following the release of its fourth-quarter financial results, which exceeded analyst expectations. The company reported Q4 revenue of 356.6 million, surpassing the consensus estimate of 337.9 million, and an adjusted earnings per share (EPS) of 0.84 compared to the expected 0.63. Additionally, Guidewire announced it has surpassed the 1 billion annual recurring revenue milestone and executed 19 cloud deals during the quarter. Analysts responded positively, with firms such as Stifel and RBC raising their price targets to 300, while Oppenheimer increased its target from 275 to 300. Following these announcements, GWRE opened significantly higher, reflecting increased market confidence.

LULU | -19.5% | -3.9B
Lululemon Athletica Inc | Apparel, Accessories & Luxury Goods
Lululemon Athletica Inc. reported mixed second-quarter results, with earnings per share of $3.10, surpassing the consensus estimate of $2.90, while revenue of $2.525 billion fell short of expectations of $2.538 billion. The company lowered its third-quarter guidance for GAAP EPS to between $2.18 and $2.23, significantly below the analyst estimate of $2.94, and projected sales of $2.470 billion to $2.500 billion, also below expectations. Lululemon revised its full-year guidance, expecting net revenue between $10.85 billion and $11 billion, down from previous estimates of $11.15 billion to $11.30 billion, and lowered its earnings forecast to between $12.77 and $12.97 per share, down from $14.58 to $14.78. Following these announcements, the stock experienced a notable decline, dropping significantly in after-hours trading and continuing its downward trajectory in pre-market activity.

IOT | +12.5% | +2.8B
Samsara Inc | Application Software
Samsara Inc reported strong financial results for the second quarter of fiscal year 2026, with an adjusted EPS of $0.12, surpassing the estimate of $0.07. Revenue reached $391.5 million, exceeding the anticipated $372.2 million, while the adjusted gross margin stood at 78%. The company raised its fiscal year 2026 guidance, projecting an adjusted EPS of $0.45-$0.47 and revenue between $1.574 billion and $1.578 billion. Annual recurring revenue (ARR) totaled $1.6 billion, reflecting a 30% increase year-over-year, alongside the addition of 17 customers generating over $1 million in ARR during the quarter. Following the earnings announcement, Samsara's stock increased approximately 7% in after-hours trading and has since risen by 13.5% in pre-market activity. Additionally, Braze Inc experienced a significant surge in its stock price, which may correlate with Samsara's movement in the market.

DOCU | +8.2% | +1.4B
DocuSign Inc | Application Software
DocuSign reported second-quarter financial results that exceeded analyst expectations, with revenue of 800.6 million compared to the estimate of 780.2 million. The company posted an adjusted EPS of 0.92, surpassing the consensus estimate of 0.84. Q2 billings reached 818 million, and the gross margin stood at 79.3%, with an adjusted gross margin of 82%. Free cash flow for the quarter was reported at 217.6 million. Following these results, DocuSign raised its fiscal year 2026 revenue guidance to a range of 3.19 billion to 3.20 billion, exceeding the previous consensus of 3.16 billion. Social media highlighted these strong earnings, contributing to a notable uptick in pre-market trading, where the stock rose by approximately 8.2%.

AVGO | +13.0% | +20.9B
Broadcom Inc | Semiconductors
Broadcom Inc. experienced a significant price increase following multiple price target upgrades from analysts after its robust fiscal third-quarter results. KeyBanc raised its price target to 400 from 330, while B of A Securities and Rosenblatt also set their targets at 400, up from 300 and 340, respectively. Citi increased its target to 350 from 315, and Truist raised its target to 365 from 295. The company reported third-quarter revenue of 15.95 billion, exceeding estimates, with notable growth attributed to custom AI accelerators and networking segments. CEO Hock Tan highlighted a 63% year-over-year increase in AI revenue, reaching 5.2 billion. Additionally, Broadcom anticipates fourth-quarter revenue of approximately 17.4 billion, surpassing analyst expectations. The actual earnings per share came in at 1.69, above the expected 1.54, with revenues reported at 16.0 billion against an expectation of 15.8 billion.

BNTX | +8.7% | +2.3B
BioNTech SE | Biotechnology
BioNTech SE has announced that its pivotal Phase 3 trial for trastuzumab pamirtecan has met its primary endpoint of progression-free survival in an interim analysis. This trial compared trastuzumab pamirtecan to trastuzumab emtansine in patients with HER2-positive unresectable or metastatic breast cancer who had previously undergone trastuzumab and taxane-based chemotherapy. The results were validated by an Independent Data Monitoring Committee and a Blinded Independent Central Review. Following this milestone, DualityBio intends to engage with China's National Medical Products Administration regarding a Biologics License Application submission. Additionally, social media discussions have emerged, criticizing prominent figures opposing Covid mRNA vaccines, with references to BioNTech and Pfizer, amidst a backdrop of shifting sentiments among Republican Senators.

Thank you for spending a minute with us. 

If you have 2 more minutes, watch this demo of the MarketReader Platform: